Modeling Within-Host Dynamics of SARS-CoV-2 Infection: A Case Study in Ferrets
- PMID: 34452499
- PMCID: PMC8402735
- DOI: 10.3390/v13081635
Modeling Within-Host Dynamics of SARS-CoV-2 Infection: A Case Study in Ferrets
Abstract
The pre-clinical development of antiviral agents involves experimental trials in animals and ferrets as an animal model for the study of SARS-CoV-2. Here, we used mathematical models and experimental data to characterize the within-host infection dynamics of SARS-CoV-2 in ferrets. We also performed a global sensitivity analysis of model parameters impacting the characteristics of the viral infection. We provide estimates of the viral dynamic parameters in ferrets, such as the infection rate, the virus production rate, the infectious virus proportion, the infected cell death rate, the virus clearance rate, as well as other related characteristics, including the basic reproduction number, pre-peak infectious viral growth rate, post-peak infectious viral decay rate, pre-peak infectious viral doubling time, post-peak infectious virus half-life, and the target cell loss in the respiratory tract. These parameters and indices are not significantly different between animals infected with viral strains isolated from the environment and isolated from human hosts, indicating a potential for transmission from fomites. While the infection period in ferrets is relatively short, the similarity observed between our results and previous results in humans supports that ferrets can be an appropriate animal model for SARS-CoV-2 dynamics-related studies, and our estimates provide helpful information for such studies.
Keywords: COVID-19; SARS-CoV-2; ferrets; viral dynamics; within-host modeling.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.EBioMedicine. 2021 Jan;63:103153. doi: 10.1016/j.ebiom.2020.103153. Epub 2020 Dec 3. EBioMedicine. 2021. PMID: 33279857 Free PMC article.
-
Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection.J Virol. 2022 Feb 9;96(3):e0145521. doi: 10.1128/JVI.01455-21. Epub 2021 Nov 24. J Virol. 2022. PMID: 34817200 Free PMC article.
-
Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection.Viruses. 2021 Jan 15;13(1):113. doi: 10.3390/v13010113. Viruses. 2021. PMID: 33467732 Free PMC article.
-
SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19.Elife. 2021 Aug 20;10:e70458. doi: 10.7554/eLife.70458. Elife. 2021. PMID: 34414888 Free PMC article.
-
Viral dynamics in the Upper Respiratory Tract (URT) of SARS-CoV-2.Infez Med. 2020 Dec 1;28(4):486-499. Infez Med. 2020. PMID: 33257622
Cited by
-
Probability of early infection extinction depends linearly on the virus clearance rate.R Soc Open Sci. 2024 Oct 2;11(10):240903. doi: 10.1098/rsos.240903. eCollection 2024 Oct. R Soc Open Sci. 2024. PMID: 39359461 Free PMC article.
-
Modeling within-host and aerosol dynamics of SARS-CoV-2: The relationship with infectiousness.PLoS Comput Biol. 2022 Aug 1;18(8):e1009997. doi: 10.1371/journal.pcbi.1009997. eCollection 2022 Aug. PLoS Comput Biol. 2022. PMID: 35913988 Free PMC article.
-
Mathematical Modeling and Analysis of the Dynamics of RNA Viruses in Presence of Immunity and Treatment: A Case Study of SARS-CoV-2.Vaccines (Basel). 2023 Jan 17;11(2):201. doi: 10.3390/vaccines11020201. Vaccines (Basel). 2023. PMID: 36851079 Free PMC article.
-
Prediction of transport, deposition, and resultant immune response of nasal spray vaccine droplets using a CFPD-HCD model in a 6-year-old upper airway geometry to potentially prevent COVID-19.Exp Comput Multiph Flow. 2023;5(3):272-289. doi: 10.1007/s42757-022-0145-7. Epub 2023 Jan 19. Exp Comput Multiph Flow. 2023. PMID: 36694695 Free PMC article.
-
Ensemble modeling of SARS-CoV-2 immune dynamics in immunologically naïve rhesus macaques predicts that potent, early innate immune responses drive viral elimination.Front Immunol. 2024 Nov 7;15:1426016. doi: 10.3389/fimmu.2024.1426016. eCollection 2024. Front Immunol. 2024. PMID: 39575237 Free PMC article.
References
-
- Chan J.F., Kok K.H., Zhu Z., Chu H., To K.K., Yuan S., Yuen K.Y. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020;9:221–236. doi: 10.1080/22221751.2020.1719902. - DOI - PMC - PubMed
-
- WHO . WHO Coronavirus (COVID-19) Dashboard. WHO; Geneva, Switzerland: 2021.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous